Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
20°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
181.21
+0.86 (+0.48%)
Streaming Delayed Price
Updated: 11:53 AM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
58
59
Next >
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Mainz Biomed (MYNZ) nominates two notable leaders in key areas of the diagnostics field to its Board of Directors
September 29, 2022
Via
AB Newswire
Check Out What Whales Are Doing With ABBV
September 27, 2022
Someone with a lot of money to spend has taken a bearish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Check Out What Whales Are Doing With ABBV
September 26, 2022
Someone with a lot of money to spend has taken a bearish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
European Authority Backs AbbVie's Crohn's Disease Candidate
September 19, 2022
Via
Benzinga
AbbVie Psoriatic Arthritis Drug Shows Long-term Effect On Skin, Joint Symptoms
September 12, 2022
Via
Benzinga
What Are Whales Doing With AbbVie
September 08, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 16 strange trades.
Via
Benzinga
S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market
September 24, 2022
Eli Lilly leads medical stocks setting up and showing relative strength.
Via
Investor's Business Daily
Biden Announces $1.5B To Combat US Overdose Epidemic, Support Recovery
September 23, 2022
Via
Benzinga
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
Via
Benzinga
7 Top-Rated Biotech Stocks to Buy for Q4
September 15, 2022
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter.
Via
InvestorPlace
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
September 15, 2022
The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.
Via
Investor's Business Daily
Analyzing AbbVie's Short Interest
September 14, 2022
AbbVie's (NYSE:ABBV) short percent of float has fallen 13.51% since its last report. The company recently reported that it has 11.38 million shares sold short, which is 0.64% of...
Via
Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
Via
Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
President Joe Biden channeled John F. Kennedy on the 60th anniversary of the former President's moonshot speech, highlighting the Biden administration's efforts to "end cancer as we know it." The...
Via
Benzinga
This Is What Whales Are Betting On AbbVie
September 13, 2022
Someone with a lot of money to spend has taken a bearish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Dividend Income Update August 2022
September 12, 2022
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio.
Via
Talk Markets
Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment
September 12, 2022
Bristol-Myers Squibb is going after Amgen's $2 billion a year Otezla franchise with Sotyktu. BMY stock is up on the news.
Via
InvestorPlace
Death Cross Looms Over AbbVie Investors
September 09, 2022
If history is any guide, there may be trouble ahead for shares of AbbVie (NYSE:ABBV). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Via
Benzinga
Some Breast Implant Cases Are Associated With Skin Cancer, FDA Receives Reports
September 09, 2022
Via
Benzinga
7 S&P 500 Stocks to Buy With Superior Fundamentals
September 08, 2022
With the market and the broader economy poised for significant changes, investors may find confidence in S&P 500 stocks to buy.
Via
InvestorPlace
Why Is Revance Therapeutics (RVNC) Stock Soaring Today?
September 08, 2022
RVNC stock is jumping 12% after the FDA approved its alternative to AbbVie's Botox. Revance's injection is supposed to last longer than Botox.
Via
InvestorPlace
AbbVie, Tesla, Financial Select Sector SPDR, iShares 20 Plus Year Treasury Bond And This Airline Are CNBC's Final Trades
September 08, 2022
On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said that AbbVie Inc (NYSE: ABBV) has “come down from 175.” “It&rsqu
Via
Benzinga
Tesla, AbbVie Are CNBC 'Fast Money' Mentions; Steve Weiss Is Shorting This ETF
September 07, 2022
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.
Via
Benzinga
Ironwood's Constipation Drug Shows Efficacy In Pediatric Patients
September 06, 2022
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) announced topline data from a Phase 3 trial evaluating Linzess (linaclotide) 72 mcg in pediatric patients aged 6-17 with functional constipation.
Via
Benzinga
Looking At AbbVie's Recent Whale Trades
September 02, 2022
Someone with a lot of money to spend has taken a bullish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
September 02, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
September 02, 2022
Via
CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
This Stock 'Benefits From Volatility,' Analyst Says On CNBC's Final Trades, Plus AbbVie And ETF Plays
September 02, 2022
CME Group Inc (NASDAQ: CME) “benefits from volatility.” That's according to Karen Firestone of Aureus Asset Management who appeared on CNBC’s “Halftime Report Final Trades.”
Via
Benzinga
Amazon, Honeywell Are CNBC 'Fast Money' Calls Of The Day; Steve Weiss Is Shorting This Sector
September 01, 2022
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
58
59
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.